Open Beta
TREN
MetriLume
TREN

US marketsYARW

SEC-sourced researchBeta

YARW

Yarrow Bioscience, Inc.

Company comparison ↗

Data passport

CIK
0001566044
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 501,000.0000 USD; December 2025: 570,000.0000 USD570K USD0 USD0December 2024December 2025
YARW · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024501,000.0000Feb 27, 2026
December 2025570,000.0000Feb 27, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025570,000.0000-26,483,000.0000-33,124,000.000030,160,000.00002,395,000.0000Feb 27, 2026
December 2024501,000.0000-39,834,000.0000-33,972,000.000066,905,000.000014,819,000.0000Feb 27, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$570KDecember 2025Feb 27, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$501KDecember 2024Feb 27, 202610-K
Net incomeNetIncomeLoss-$26.48MDecember 2025Feb 27, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$33.12MDecember 2025Feb 27, 202610-K
Total assetsAssets$30.16MDecember 2025Feb 27, 202610-K
Total liabilitiesLiabilities$2.4MDecember 2025Feb 27, 202610-K

New filings

Explore methodology ↗